These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27041577)

  • 21. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
    Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
    Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.
    Madigan CE; Armenian SH; Malogolowkin MH; Mascarenhas L
    Cancer; 2007 Nov; 110(9):2061-6. PubMed ID: 17828773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
    Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
    Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
    Mikami M; Masuda T; Kanatani T; Noura M; Umeda K; Hiramatsu H; Kubota H; Daifu T; Iwai A; Hattori EY; Furuichi K; Takasaki S; Tanaka S; Matsui Y; Matsuo H; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Imai Y; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Mol Cells; 2022 Dec; 45(12):886-895. PubMed ID: 36572559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
    Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
    Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
    Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
    Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classical malignant rhabdoid tumor of central nervous system in 9-year-old Korean.
    Chang HK; Kim JH
    Yonsei Med J; 2001 Feb; 42(1):142-6. PubMed ID: 11293495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAIL/Apo2L ligands induce apoptosis in malignant rhabdoid tumor cell lines.
    Yoshida S; Narita T; Koshida S; Ohta S; Takeuchi Y
    Pediatr Res; 2003 Nov; 54(5):709-17. PubMed ID: 12904602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors.
    Calandrini C; van Hooff SR; Paassen I; Ayyildiz D; Derakhshan S; Dolman MEM; Langenberg KPS; van de Ven M; de Heus C; Liv N; Kool M; de Krijger RR; Tytgat GAM; van den Heuvel-Eibrink MM; Molenaar JJ; Drost J
    Cell Rep; 2021 Aug; 36(8):109568. PubMed ID: 34433038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity.
    Katsumi Y; Kuwahara Y; Tamura S; Kikuchi K; Otabe O; Tsuchiya K; Iehara T; Kuroda H; Hosoi H; Sugimoto T
    Clin Cancer Res; 2008 Feb; 14(4):1192-9. PubMed ID: 18281554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological features of paediatric malignant rhabdoid tumours.
    Morgenstern DA; Gibson S; Brown T; Sebire NJ; Anderson J
    Pediatr Blood Cancer; 2010 Jan; 54(1):29-34. PubMed ID: 19653294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
    Abou Asa S
    J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
    Hakozaki M; Hojo H; Kikuchi S; Abe M
    Oncol Rep; 2007 Jan; 17(1):169-73. PubMed ID: 17143495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma.
    Higashino K; Narita T; Taga T; Ohta S; Takeuchi Y
    Cancer Sci; 2003 Jan; 94(1):37-42. PubMed ID: 12708472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
    Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation.
    Shiratsuchi H; Saito T; Sakamoto A; Itakura E; Tamiya S; Oshiro Y; Oda Y; Toh S; Komiyama S; Tsuneyoshi M
    Mod Pathol; 2002 Feb; 15(2):146-53. PubMed ID: 11850543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.